Dimensional Fund Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$889K Buy
475,844
+146,721
+45% +$387K ﹤0.01% 2887
2026
Q1
$1.27M Buy
329,123
+43,684
+15% +$107K ﹤0.01% 2797
2025
Q4
$556K Sell
285,439
-79,236
-22% -$130K ﹤0.01% 2957
2025
Q3
$308K Sell
364,675
-186,065
-34% -$137K ﹤0.01% 3065
2025
Q2
$399K Sell
550,740
-109,178
-17% -$82K ﹤0.01% 3026
2025
Q1
$568K Sell
659,918
-110,435
-14% -$164K ﹤0.01% 2985
2024
Q4
$1.29M Buy
770,353
+78,367
+11% +$187K ﹤0.01% 2877
2024
Q3
$1.97M Buy
691,986
+117,142
+20% +$303K ﹤0.01% 2782
2024
Q2
$1.34M Buy
574,844
+94,908
+20% +$248K ﹤0.01% 2859
2024
Q1
$1.41M Buy
479,936
+78,911
+20% +$224K ﹤0.01% 2860
2023
Q4
$1.2M Buy
401,025
+158,073
+65% +$452K ﹤0.01% 2896
2023
Q3
$767K Buy
242,952
+162,991
+204% +$531K ﹤0.01% 2973
2023
Q2
$308K Buy
79,961
+53,091
+198% +$153K ﹤0.01% 3152
2023
Q1
$74.4K Buy
+26,870
New +$56.4K ﹤0.01% 3348

Other funds holding NAUT

Dimensional Fund Advisors's NAUT Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Nautilus Biotechnolgy (NAUT) stake by 45% in Q2 2026, buying an estimated $387K and bringing the position to 475,844 shares worth $889K. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

Dimensional Fund Advisors first reported a position in NAUT in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.97M in Q3 2024. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Dimensional Fund Advisors held 475,844 shares of Nautilus Biotechnolgy worth $889K as of Q2 2026.
  • Dimensional Fund Advisors bought 146,721 Nautilus Biotechnolgy shares in Q2 2026, an estimated $387K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2887 holding.
  • Dimensional Fund Advisors first reported a position in Nautilus Biotechnolgy in Q1 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Nautilus Biotechnolgy position peaked at $1.97M in Q3 2024.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.